Mike Davidson Email Address

Information Technology Director

Intarcia Therapeutics, Inc., incorporated in June 1995, is a biopharmaceutical company with an approach to acquire, develop and commercialize therapeutic products for the treatment of cancer and infectious diseases. The Company is developing atamestane, its aromatase inhibitor, in combination with toremifene, an approved estrogen receptor blocker, for the treatment of hormone-dependent breast cancer in postmenopausal women. During the year ended December 31, 2004, Intarcia Therapeutics, Inc. was in Phase III clinical development with this combination for the initial or first line treatment of hormone-dependent advanced (metastatic or locally advanced) breast cancer in postmenopausal women. It is developing omega DUROS, a subcutaneous implant designed to deliver its omega interferon, for the treatment of hepatitis C. The Company has completed a Phase II clinical trial of omega interferon.

Skills Strategy - Aligning information technology with business requirements. Planning – Requirements, road map, budgeting. Execution - Results driven with strong customer service focus and budget compliance. Regulatory Compliance: SOX, FDA. Experienced Manager – Staff of 3 to 50+: Recruitment, retention, and development. Vendor Management – Identification, negotiation, staff augmentation, project, service, utility. An IT Leader with 20 years of experience in startup, mid-size, and Fortune 100 companies. A person with the ability to plan for and manage multiple, competing, priorities, in fast paced and quickly changing environments with a high degree of quality and customer satisfaction. Comfortable wearing multiple hats and successful at contributing to the organization as an individual, team member, and leader. Specialties: IT Regulatory compliance (FDA, GxP, SOX, etc) Vendor Management Strong Customer Service focus Extremely Flexible and Adaptable to Business requirments/changes. Creating and executing IT Strategy